Loading...
EQ EQUILLIUM INC Product Launches 8-K Filing
Back
QLLM
Q
EQUILLIUM INC
(EQ)
Follow
FY2025 8 K
View More
Back
QLLM
Q
EQUILLIUM INC
(EQ)
Follow
FY2025 8 K
Filing:
8 K
Published on:
6 Feb '25
Financial Statements
24 Apr '25
Financial Results
27 Mar '25
Clinical Trial Results
6 Feb '25
Nasdaq Noncompliance
13 Dec '24
Board Changes
12 Dec '24
Q3 Financial Results
13 Nov '24
Itolizumab Update
31 Oct '24
Nasdaq Compliance
30 Oct '24
Delisting
23 Jul '24
Financial Condition
18 Jul '24
Phase 2 Study Results
4 Jun '24
Annual Meeting of Stockholders
23 May '24
Financial Results Announcement
9 May '24
Positive Data from Phase 1b...
1 Apr '24
Financial Results Announcement
25 Mar '24
Appointment of Principal Ac...
8 Mar '24
Results of Operations and F...
23 Feb '24
Compliance Regained
22 Feb '24
EQ101 Phase 2 Study Enrollm...
21 Dec '23
Financial Results and Study...
8 Nov '23
Equillium Investor Day
16 Oct '23
Open Market Sale Agreement
5 Oct '23
Earnings Reports
9 Aug '23
Termination of Loan Agreement
25 May '23
Annual Meeting of Stockholders
23 May '23
Financial Results Announcement
11 May '23
Delisting
6 Apr '23
Financial Results Announcement
23 Mar '23
External Links:
SEC
AI Assistant
Close
EQUILLIUM INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.